Takahiro Yamauchi Selected Research

Takahiro Yamauchi Research Topics

Disease

35	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 11/2003
27	Neoplasms (Cancer) 03/2024 - 02/2002
25	Leukemia 03/2024 - 06/2002
11	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 11/2006
10	Lymphoma (Lymphomas) 09/2023 - 03/2007
8	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016 - 06/2010
7	Neutropenia 01/2024 - 03/2002
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2023 - 11/2012
6	Acute Promyelocytic Leukemia 01/2023 - 02/2003
6	Multiple Myeloma 01/2022 - 01/2014
5	Febrile Neutropenia 10/2022 - 12/2013
5	Pneumonia (Pneumonitis) 08/2021 - 05/2009
5	Disease Progression 05/2021 - 09/2012
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2020 - 02/2010
5	Hyperuricemia 01/2015 - 04/2008
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2024 - 12/2017
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2023 - 07/2007
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023 - 12/2018
4	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2013
4	Infections 02/2021 - 03/2002
4	Nausea 04/2019 - 12/2013
4	Disseminated Intravascular Coagulation 11/2018 - 01/2011
4	Tumor Lysis Syndrome 12/2016 - 10/2014
4	Carcinogenesis 07/2011 - 05/2007
4	Colonic Neoplasms (Colon Cancer) 07/2011 - 03/2010
3	Anemia 01/2020 - 12/2013
3	Vomiting 04/2019 - 11/2017
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2014 - 06/2008
2	Hematologic Diseases (Blood Diseases) 09/2023 - 04/2013
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 09/2023 - 02/2010
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023 - 10/2022
2	Liver Diseases (Liver Disease) 10/2022 - 10/2017
2	Diarrhea 10/2022 - 04/2019
2	Fever (Fevers) 03/2021 - 01/2017
2	Bacteremia 02/2021 - 04/2013
2	Sepsis (Septicemia) 02/2021 - 06/2002
2	Inflammation (Inflammations) 01/2020 - 01/2018
2	Hematoma 10/2018 - 10/2017
2	Neoplasm Metastasis (Metastasis) 10/2017 - 03/2002
2	Hemorrhage 10/2017 - 01/2011
2	Pancytopenia 01/2017 - 10/2012
2	Myeloid Leukemia (Leukemia, Myelocytic) 10/2014 - 04/2014

Drug/Important Bio-Agent (IBA)

16	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2024 - 02/2003
8	Uric Acid (Urate)IBA 05/2015 - 04/2008
6	venetoclaxIBA 01/2022 - 10/2020
6	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 06/2002
6	DNA (Deoxyribonucleic Acid)IBA 07/2019 - 11/2002
6	ErbB Receptors (EGF Receptor)IBA 12/2011 - 06/2010
5	Bortezomib (Velcade)FDA Link 01/2022 - 12/2016
5	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 07/2007
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 12/2013
4	Rituximab (Mabthera)FDA Link 03/2024 - 01/2014
4	Azacitidine (5 Azacytidine)FDA Link 03/2023 - 05/2021
4	Clofarabine (Clolar)FDA Link 10/2020 - 09/2011
4	Phosphotransferases (Kinase)IBA 11/2015 - 06/2008
4	Carmustine (FIVB)FDA Link 08/2015 - 11/2002
4	9-arabinofuranosylguanineIBA 09/2014 - 02/2010
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2014 - 03/2005
4	Gemcitabine FDA Link 12/2011 - 11/2006
4	Epidermal Growth Factor (EGF)IBA 07/2011 - 03/2010
4	Proteins (Proteins, Gene)FDA Link 06/2010 - 04/2008
3	Messenger RNA (mRNA)IBA 09/2023 - 10/2012
3	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 02/2015
3	nelarabine (506U78)FDA Link 10/2019 - 02/2010
3	forodesineIBA 01/2019 - 09/2014
3	Dacarbazine (DIC)FDA LinkGeneric 11/2018 - 01/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2017 - 02/2002
3	Febuxostat FDA Link 01/2015 - 10/2014
3	p38 Mitogen-Activated Protein KinasesIBA 11/2011 - 06/2010
3	triphosphoric acid (triphosphate)IBA 09/2011 - 11/2006
3	Cyclin D1IBA 07/2011 - 03/2008
3	rho-Associated KinasesIBA 07/2011 - 03/2010
2	Bendamustine Hydrochloride FDA Link 03/2024 - 01/2014
2	EnzymesIBA 03/2024 - 04/2019
2	Tyrosine Kinase InhibitorsIBA 07/2023 - 09/2010
2	alovudineIBA 01/2023 - 02/2019
2	Gemtuzumab (Mylotarg)FDA Link 03/2021 - 10/2014
2	Purine-Nucleoside PhosphorylaseIBA 01/2019 - 09/2014
2	ThrombomodulinIBA 11/2018 - 01/2011
2	SurvivinIBA 12/2017 - 09/2012
2	R-CHOP protocolIBA 12/2017 - 11/2012
2	Methotrexate (Mexate)FDA LinkGeneric 10/2017 - 02/2014
2	Immunoglobulin G (IgG)IBA 01/2017 - 01/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 02/2014
2	Becaplermin (PDGF-BB)FDA Link 07/2016 - 04/2012
2	Platelet-Derived Growth FactorIBA 07/2016 - 04/2012
2	Temozolomide (Temodar)FDA LinkGeneric 08/2015 - 07/2008
2	purineIBA 12/2014 - 01/2014
2	Xanthine OxidaseIBA 12/2014 - 10/2014
2	Dasatinib (BMS 354825)FDA Link 02/2014 - 06/2011
2	Alanine Transaminase (SGPT)IBA 12/2013 - 05/2007

Therapy/Procedure

32	Drug Therapy (Chemotherapy) 01/2024 - 03/2002
31	Therapeutics 03/2024 - 03/2002
3	Hematopoietic Stem Cell Transplantation 10/2022 - 10/2013
3	Induction Chemotherapy 05/2021 - 01/2011
3	Remission Induction 01/2011 - 06/2002
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 11/2023 - 03/2008
2	Transplantation 11/2023 - 01/2017
2	Craniotomy 09/2023 - 10/2017
2	Radiotherapy 10/2017 - 05/2009